Grifols, S.A. ROE Ratio 2011-2026 | GRFS

Annual ROE Ratio Grifols, S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	9.2	14.4	18.25	20.09	23.63	25.72	26.75	30.99	27.68	6.6

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
30.99	6.6	20.33

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Burford Capital Limited BUR	10.1	$ 4.73	0.42 %	$ 761 M	Britain
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	39.76	$ 333.39	-1.77 %	$ 43.7 B	USA
Can-Fite BioPharma Ltd. CANF	-175.75	$ 3.17	3.93 %	$ 5.22 M	Israel
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alterity Therapeutics Limited ATHE	-36.22	$ 3.73	3.04 %	$ 8.97 B	Australia
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	-45.18	$ 7.42	-15.1 %	$ 73.3 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	103.22	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	12.44	$ 21.68	1.4 %	$ 1.01 B	USA
Cabaletta Bio CABA	-149.8	$ 3.4	4.29 %	$ 342 M	USA
CymaBay Therapeutics CBAY	-36.05	-	-	$ 3.45 B	USA
BioNTech SE BNTX	1.11	$ 99.47	1.08 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	549.72	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	-16.39	-	-	$ 399 M	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	248.9	$ 4.24	2.17 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 24.58	-2.03 %	$ 3.13 B	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	45.18	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	-161.42	$ 1.49	0.68 %	$ 397 M	Britain
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	445.47	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-67.58	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	-49.08	$ 33.87	1.62 %	$ 2.25 B	USA
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	204.15	-	-	$ 25.3 M	USA
bluebird bio BLUE	-108.93	-	-	$ 546 M	USA
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA